Reminder: Changes in Hepatitis C Treatment Coverage for Medicaid Clients Begins Jan. 1 The Texas Health and Human Services Commission (HHSC) recently partnered with AbbVie to work toward significantly reducing chronic Hepatitis C in Medicaid patients. HHSC will publish an update to the Texas Medicaid Preferred Drug List (PDL) on Jan. 1 to designate preferred and non-preferred options for direct-acting antiviral (DAA) treatment. Other news Younger Age Groups Now Eligible For Updated Bivalent COVID-19 Vaccines Annual Review of Clinical Prior Authorization Criteria Guides to Begin; Changes Scheduled for Feb. 7 Androgenic Agents Clinical Prior Authorization Revisions Scheduled for Feb. 1, 2023 Semi-annual Medicaid Preferred Drug List Update Coming Jan. 26

---

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

---

Stay Connected
					(en español)

Subscriber Services
Manage Preferences  |  Unsubscribe  |  Help

This email was sent to ooseims.archieves@blogger.com using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202